Sign in to view content

Phase 2a Study of CU06-1004, an Oral Endothelial Dysfunction Blocker For the Treatment of Diabetic Macular Edema (DME)

Victor Hugo Gonzalez, MD

Video
Published 2024

Related

Prospective Evaluation of Pain and Inflammation Following Injection of Aflibercept or Ranibizumab in Patients With Diabetic Macular Edema: SOLAR Study
Nikolas JS London, MD, FACS, FASRS
Annual Meeting Talks
2018
Geographic Trends in the Recruitment of Participants of Racial and Ethnic Minorities for Diabetic Retinopathy-Related Clinical Trials
Vivienne S. Hau, MD, PhD
Annual Meeting Talks
2023
Hyalocyte Apoptosis in Vitreous Microparticles Suggest a Diabetic Vitreopathy
Harris C Sultan, MS, MD
On Demand Cases, Courses, and Papers
2019

Category: Diabetic Retinopathy

See more